Carbamazepine-10,11-epoxide measurement

Hermida J & Tutor JC: How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples. Ther Drug Monit 2003; 25(3):384-388.

Parant F, Bossu H, Gagnieu MC, et al: Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000. Ther Drug Monit 2003; 25(1):41-45.

Winnicka RI, Lopacinski B, Szymczak WM, et al: Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol 2002; 40(6):759-765.

Minkova G & Getova D: Determination of carbamazepine and its metabolite carbamazepine-10,11-epoxide in serum with gas-chromatography mass spectrometry. Methods Find Exp Clin Pharmacol 2001; 23(9):481-485.

Montgomery VL, Richman BJ, Goldsmith LJ, et al: Severity and carbamazepine level at time of initial poison center contact correlate with outcome in carbamazepine poisoning. J Toxicol Clin Toxicol 1995; 33(4):311-323.